Fang Qing (方清)方清
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 山东新时代药业有限公司Chinese legal name: 山东新时代药业有限公司
主要成分Active Ingredients
- 多奈哌齐Duonai Paiqi
药物知识说明
多奈哌齐是一种在国家药监局注册认定的药品。该药品含有多奈哌齐-92dbe933等成分。
该药品关联的活性成分包括:多奈哌齐Duonai Paiqi。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为:山东新时代药业有限公司Chinese legal name: 山东新时代药业有限公司。
您可以探索含有相同成分的其他药品:多奈哌齐-92dbe933成分药品。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 方清) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 多奈哌齐Duonai Paiqi.
Manufacturers recorded for this product: 山东新时代药业有限公司Chinese legal name: 山东新时代药业有限公司.
Explore other medicines containing the same ingredient: 多奈哌齐 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 方清Recorded Chinese name: 方清
- 剂型Dosage form: 滴丸剂Recorded Chinese dosage form
- 规格Specification: 2.5mg2.5 mg
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 山东新时代药业有限公司Chinese legal name: 山东新时代药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20051954
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20051954
Manufacturer
Chinese legal name: 山东新时代药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20051954
生产企业
山东新时代药业有限公司(国产)
适应症
用于治疗轻中度阿尔茨海默病。
用法用量
1.成人 (1)常规剂量 (2)口服给药 初始剂量一次5mg,一日1次,睡前服用,至少维持1个月,作出临床评估后,可以将剂量增加到一次10mg,一日1次,睡前服用。推荐最大剂量为一日10mg。3-6月为一个疗程。 2给药说明: (1)服用本药时病人患溃疡病的危险性增大。如有溃疡病史或服用合成非甾体类抗炎药物的病人应密切观察其症状。 (2)使用本药对驾驶车辆或操纵机器无影响,但阿尔茨海默病患者本身可能对其有影响。
不良反应
1.常见、恶心、呕吐、腹泻、乏力、倦怠、肌肉痉挛、食欲缺乏等,症状常为一过性、轻度的反应,继续用药可缓解。实验室检查可见血肌酸激酶轻微升高,其它检验值尚未发现明显异常。
2.较少见头晕、头痛、精神紊乱。
禁忌
对本药或哌啶衍生物过敏者。
注意事项
慎用:
1.接受非甾体类抗炎药治疗的患者。
2.哮喘或阻塞性肺病患者。
3.病窦综合征或室上性传导阻滞患者(本药可能引起心动过缓)。
4.有癫痫发作史者(拟胆碱作用可能引起。
贮藏
密封,置阴凉处。
规格
2.5mg
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.